BRANMOOR
THURSDAY · 14 MAY 2026

Dobutamine Hydrochloride

Injection · trading as Dobutamine Hydrochloride In Dextrose

Current Active — Day 3111 FDA record updated

High impact — Only one manufacturer supplies this drug; any disruption leaves no immediate alternative source.

FDA shortage record

Substance
Dobutamine Hydrochloride
Brand name
Dobutamine Hydrochloride In Dextrose
Manufacturers / suppliers
  • Baxter Healthcare Corporation
  • Baxter Healthcare
2 known suppliers in current FDA data
Dosage form
Injection
Presentation
Dobutamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 200 mg/100 mL (NDC 0338-1075-02)
Route(s)
INTRAVENOUS
Therapeutic category
Cardiovascular, Pediatric, Renal
Package NDC
0338-1075-02
Initially posted
11/06/2017
Days on shortage list
3111
Current FDA status
Current
Shortage entries (current dataset)
1 record for Dobutamine Hydrochloride

Why this shortage matters

Cardiovascular drugs manage heart failure, arrhythmias, hypertension, and coronary artery disease. Shortages can disrupt stable long-term therapy or create gaps in acute care where dosing consistency is essential to preventing cardiac events.

FDA therapeutic class: Cardiovascular, Pediatric, Renal

Manufacturer contact

Per the FDA record, the manufacturer's contact for supply inquiries is 888-229-0001.

If you're affected by this shortage

  • Talk to your prescribing clinician or pharmacist about therapeutic alternatives. Do not switch medications on your own.
  • Ask your pharmacy to check supply across multiple wholesalers and other branches.
  • Check current pharmacy pricing and availability via GoodRx (affiliate link).
  • Report a continuing supply problem to FDA via the FDA Drug Shortages contact form.

Sources

Important

This page reproduces publicly available FDA shortage data for informational purposes only. It is not medical advice and does not establish a clinician-patient relationship. Shortage status changes frequently; verify directly with your pharmacist or the FDA Drug Shortages site before making any treatment decision.